TCTR20220322002已完成3 期
Increasing dose of radioactive iodine in Graves' disease with historical control
Phrapokklao Hospital0 个研究点目标入组 219 人开始时间: 2022年3月22日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 219
研究概览
简要总结
Higher dosage (20 mCi) RAI showed superior efficacy in achieving remission compared to lower dosages (10 - 15 mCi) in Graves disease treatment.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Patiens with a diagnosis of Graves' disease in ICD10 code
- •2. Age 18 or older
排除标准
- •1. Pregnancy or lactation
- •2. Received previous radioactive iodine or surgery
- •3. Co-existing or suspicious thyroid cancer
- •4. Active or severe Graves' orbitopathy
- •5. Hyperthyroidism from other causes such as toxic adenoma, toxic multinodular goiter or thyroiditis
研究者
相似试验
已完成
3 期
Comparison of Different Doses of 131I in Severe Graves' HyperthyroidismGraves DiseaseNCT01039818Hospital de Clinicas de Porto Alegre30
Unknown
不适用
Comparative Study of Different I-131 Doses in Graves' DiseaseGraves' DiseaseNCT02114619Mashhad University of Medical Sciences450
招募中
2 期
Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancers With MAPK InhibitionMetastatic Thyroid CancerNCT04619316University Hospital, Essen70
已完成
2 期
Radioactive Iodide Therapy for Pediatric Graves' DiseaseGraves' DiseaseNCT01269749University of Florida19
已完成
不适用
Effective Iodide Therapy for Untreated Patients With Graves' Hyperthyroidism Avoiding Thionamide Drugs With Many Side EffectsGraves DiseaseNCT04686006Kyushu University504